[go: up one dir, main page]

MX9604802A - Tratamiento de fallo cardiaco congestivo. - Google Patents

Tratamiento de fallo cardiaco congestivo.

Info

Publication number
MX9604802A
MX9604802A MX9604802A MX9604802A MX9604802A MX 9604802 A MX9604802 A MX 9604802A MX 9604802 A MX9604802 A MX 9604802A MX 9604802 A MX9604802 A MX 9604802A MX 9604802 A MX9604802 A MX 9604802A
Authority
MX
Mexico
Prior art keywords
increased
treatment
left ventricular
heart failure
congestive heart
Prior art date
Application number
MX9604802A
Other languages
English (en)
Other versions
MXPA96004802A (es
Inventor
Stuart Bunting
Ross Clark
Nancy Gillett
Hongkui Jin
Renhui Yang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US1995/003760 external-priority patent/WO1995028173A1/en
Publication of MXPA96004802A publication Critical patent/MXPA96004802A/es
Publication of MX9604802A publication Critical patent/MX9604802A/es

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un mamífero con fallo cardíaco congestivo es tratado al administrar al mamífero una cantidad efectiva de hormona del crecimiento. El tratamiento resulta en una presion cistolica ventricular izquierda aumentada, un máximo ventricular izquierdo aumentado, un gasto cardíaco aumentado y un índice de volumen cistolico aumentado. El tratamiento también resulta en una presion disatolica final ventricular izquierda reducida y una resistencia vascular sistémica reducida. Esta mediciones indican mejoras en la funcion cardíaca por una capacidad de contraccion ventricular aumentada y una resistencia ventricular periférica disminuida.
MX9604802A 1995-03-30 1995-03-30 Tratamiento de fallo cardiaco congestivo. MX9604802A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08228548 1994-04-15
PCT/US1995/003760 WO1995028173A1 (en) 1994-04-15 1995-03-30 Treatment of congestive heart failure

Publications (2)

Publication Number Publication Date
MXPA96004802A MXPA96004802A (es) 1998-02-01
MX9604802A true MX9604802A (es) 1998-02-28

Family

ID=39164988

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604802A MX9604802A (es) 1995-03-30 1995-03-30 Tratamiento de fallo cardiaco congestivo.

Country Status (1)

Country Link
MX (1) MX9604802A (es)

Similar Documents

Publication Publication Date Title
CA2185999A1 (en) Treatment of congestive heart failure
Sanders et al. Importance of the duration of inadequate coronary perfusion pressure on resuscitation from cardiac arrest
CA2065973A1 (en) Rate adaptive pacemaker controlled by ejection fraction
Samet et al. Hemodynamic effects of tachycardias produced by atrial and ventricular pacing
DE3688322D1 (de) Auf uebung ansprechender, die schlagrate anpassender herzschrittmacher.
EP0600631A3 (en) Implantable two-chamber pacemaker with an adaptive A-V delay to avoid the collapse of the ventricular stimulation pulses and pounding.
US5861009A (en) Implantable cardiac stimulator with rate-adaptive T-wave detection
DE3568008D1 (en) Device for the physiological frequence control of a heart pacemaker using an excitation electrode
Samet et al. Effect of alterations in ventricular rate on cardiac output in complete heart block
ES8101378A1 (es) Protesis cardiaca total y procedimiento de regulacion del caudal sanguineo en la misma.
DE69220438D1 (de) Durch die isovolumetrische Kontraktionszeit geregelter, ratenanpassender Herzschrittmacher
Kusukawa et al. Haemodynamic effects of a new anti-anginal drug, diltiazem hydrochloride
NO940180L (no) Anvendelse av IGF-I
HORVAT et al. Effect of oxygen breathing on pacing-induced angina pectoris and other manifestations of coronary insufficiency
FR2360311A1 (fr) Polysaccharide et ses applications pour le renforcement du debit cardiaque
Tagawa et al. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: Proposal for a hematocrit most beneficial to hemodynamics
MX9604802A (es) Tratamiento de fallo cardiaco congestivo.
GB1161579A (en) Improvements in or relating to Cardiac Stimulators
Hatano et al. Usefulness of rate responsive atrial pacing in patients with sick sinus syndrome
Matlof et al. Idiopathic hypertrophic subaortic stenosis and heart block: Cycle-to-cycle variation as a function of alterations in preload and afterload
Wish et al. Hemodynamics of AV synchrony and rate
Ishikawa et al. Optimization of atrioventricular delay and follow-up in a patient with congestive heart failure and with bi-ventricular pacing
DE59600705D1 (de) Vorrichtung zur unterstützung der herztätigkeit mit hilfe eines ballons
Trigano et al. Left ventricular pressure measurement during noninvasive transcutaneous cardiac pacing
SU1761121A1 (ru) Способ определени режима посто нной электрокардиостимул ции